PH25428A - 1,4-disubstitued-pyridinyl compounds - Google Patents

1,4-disubstitued-pyridinyl compounds

Info

Publication number
PH25428A
PH25428A PH37853A PH37853A PH25428A PH 25428 A PH25428 A PH 25428A PH 37853 A PH37853 A PH 37853A PH 37853 A PH37853 A PH 37853A PH 25428 A PH25428 A PH 25428A
Authority
PH
Philippines
Prior art keywords
group
positions
phenyl ring
disubstituted
alkyl groups
Prior art date
Application number
PH37853A
Other languages
English (en)
Inventor
Albert A Carr
Thaddeus R Nieduzak
Francis P Miller
Stephen M Sorensen
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PH25428A publication Critical patent/PH25428A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
PH37853A 1987-11-24 1988-11-24 1,4-disubstitued-pyridinyl compounds PH25428A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12469287A 1987-11-24 1987-11-24
US07/254,208 US4870083A (en) 1987-11-24 1988-10-11 1,4-Disubstituted-piperidinyl compounds useful as analgesics and muscle relaxants

Publications (1)

Publication Number Publication Date
PH25428A true PH25428A (en) 1991-07-01

Family

ID=26822854

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37853A PH25428A (en) 1987-11-24 1988-11-24 1,4-disubstitued-pyridinyl compounds

Country Status (17)

Country Link
US (1) US4870083A (fr)
EP (1) EP0317997B1 (fr)
JP (1) JP2835730B2 (fr)
KR (1) KR0143091B1 (fr)
CN (1) CN1019974C (fr)
AT (1) ATE107282T1 (fr)
AU (1) AU615494B2 (fr)
CA (1) CA1330086C (fr)
DE (1) DE3850222T2 (fr)
DK (1) DK653788A (fr)
ES (1) ES2056876T3 (fr)
FI (1) FI885391A (fr)
HU (1) HU199793B (fr)
IL (1) IL88415A0 (fr)
NO (1) NO173276C (fr)
PH (1) PH25428A (fr)
PT (1) PT89064B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
US5162342A (en) * 1988-01-21 1992-11-10 Merrell Dow Pharmaceuticals Inc. Use of 1,4-disubstituted-piperidinyl compounds for analgesia and muscle relaxation
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
FR2681319B1 (fr) * 1991-09-12 1995-02-17 Synthelabo Derives de 1-(phenoxyalkyl)piperidine, leur preparation et leur application en therapeutique.
GB2418889B (en) * 2004-10-05 2006-10-04 Sumitomo Chemical Co Laminated product and process for producing the same
GB0519879D0 (en) 2005-09-30 2005-11-09 Astrazeneca Ab Chemical process
EP2865381A1 (fr) 2006-05-18 2015-04-29 Pharmacyclics, Inc. Inhibiteurs de ITK pour le traitement des cancers des cellules sanguines

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4034527Y1 (fr) * 1964-04-09 1965-12-03
FR2092133B1 (fr) * 1970-05-06 1974-03-22 Orsymonde
US3852455A (en) * 1970-11-27 1974-12-03 Richardson Merrell Inc 4-{8 4({60 hydroxybenzyl)piperidino{9 -4-fluorobutyrophenone derivatives as tranquilizers
US3888867A (en) * 1972-05-03 1975-06-10 Richardson Merrell Inc 4-(4-(alpha-hydroxybenzyl)piperidino)4'-fluorobutyrophenone derivatives
US4101662A (en) * 1973-05-03 1978-07-18 A. H. Robins Company, Incorporated Method for inhibiting emesis and compositions therefor
JPS532474A (en) * 1976-06-26 1978-01-11 Yoshitomi Pharmaceut Ind Ltd Aminoketone derivatives
JPS59217335A (ja) * 1983-05-25 1984-12-07 Toshiba Corp 半導体装置
JPS612662A (ja) * 1984-06-15 1986-01-08 Matsushita Electric Ind Co Ltd 原稿給送装置
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
JPH06950B2 (ja) * 1985-07-26 1994-01-05 石川島播磨重工業株式会社 イオンプレ−テイング装置
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체

Also Published As

Publication number Publication date
FI885391A (fi) 1989-05-25
EP0317997A2 (fr) 1989-05-31
FI885391A0 (fi) 1988-11-21
DK653788D0 (da) 1988-11-23
ES2056876T3 (es) 1994-10-16
HUT48586A (en) 1989-06-28
DE3850222D1 (de) 1994-07-21
CA1330086C (fr) 1994-06-07
PT89064B (pt) 1993-04-30
NO173276B (no) 1993-08-16
AU615494B2 (en) 1991-10-03
AU2572488A (en) 1989-05-25
EP0317997A3 (en) 1990-10-10
JPH02138174A (ja) 1990-05-28
NO885224L (no) 1989-05-25
HU199793B (en) 1990-03-28
NO173276C (no) 1993-12-01
PT89064A (pt) 1988-12-01
DE3850222T2 (de) 1994-09-22
KR890008095A (ko) 1989-07-08
CN1034202A (zh) 1989-07-26
KR0143091B1 (ko) 1998-07-15
IL88415A0 (en) 1989-06-30
ATE107282T1 (de) 1994-07-15
EP0317997B1 (fr) 1994-06-15
CN1019974C (zh) 1993-03-03
DK653788A (da) 1989-05-25
NO885224D0 (no) 1988-11-23
JP2835730B2 (ja) 1998-12-14
US4870083A (en) 1989-09-26

Similar Documents

Publication Publication Date Title
ZA902170B (en) Treatment and compounds
YU17591A (sh) Triazolni fungicidni agensi
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
CO4410329A1 (es) Nuevos pirrolocarbazoles
EP0317997A3 (en) 1,4-disubstituted-piperidinyl compounds
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
GB9125970D0 (en) New compounds
ATE105565T1 (de) Pradimicinderivate.
ES8505653A1 (es) Procedimiento para preparar un n-alquil-(3 o 4)piperidinil benzoato
GB8605032D0 (en) Fungicides
DE3561818D1 (en) Isoxazoloquinolinone derivatives, process and intermediates for their preparation, use as medicaments and compositions containing them
ES8604901A1 (es) Un procedimiento para la preparacion de un triazol
ES8200661A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina
GB8821817D0 (en) Prostaglandins of f series
MX9708891A (es) Piperidinas n-(arilmetil substituidas)-4-(bis(fenil o piridil substituidas)metil)insecticidas.